+Search query
-Structure paper
Title | Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard. |
---|---|
Journal, issue, pages | Mol Ther Methods Clin Dev, Vol. 29, Page 460-472, Year 2023 |
Publish date | Jun 8, 2023 |
Authors | Mario Mietzsch / Weijing Liu / Ke Ma / Antonette Bennett / Austin R Nelson / Keely Gliwa / Paul Chipman / Xiaofeng Fu / Shane Bechler / Robert McKenna / Rosa Viner / |
PubMed Abstract | Adeno-associated viruses (AAVs) are non-enveloped ssDNA icosahedral T = 1 viruses used as vectors for clinical gene delivery. Currently, there are over 200 AAV-related clinical trials and six ...Adeno-associated viruses (AAVs) are non-enveloped ssDNA icosahedral T = 1 viruses used as vectors for clinical gene delivery. Currently, there are over 200 AAV-related clinical trials and six approved biologics on the market. As such new analytical methods are continually being developed to characterize and monitor the quality and purity of manufactured AAV vectors, these include ion-exchange chromatography and Direct Mass Technology. However, these methods require homogeneous analytical standards with a high molecular weight standard comparable to the mass of an AAV capsid. Described here is the design, production, purification, characterization, and the cryo-electron microscopy structure of an AAV1-VP3-only capsid that fulfills this need as a calibrant to determine capsid mass, charge, homogeneity, and transgene packaging characteristics. |
External links | Mol Ther Methods Clin Dev / PubMed:37273903 / PubMed Central |
Methods | EM (single particle) |
Resolution | 2.27 Å |
Structure data | EMDB-29377, PDB-8fq4: |
Source |
|
Keywords | VIRUS LIKE PARTICLE / AAV / gene therapy / capsid / VP3 |